C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/68 (2006.01)
Patent
CA 2515096
The present invention concerns prognostic markers associated with cancer. In particular, the invention concerns prognostic methods based on the molecular charaterization of gene expression in paraffin-embedded, fixed samples of cancer tissue, which allow a physician to predict whether a patient is likely to respond well to treatment with an EGFR inhibitor.
La présente invention porte sur des marqueurs prédictifs associés au cancer. L'invention porte notamment sur des procédés prédictifs basés sur la caractérisation moléculaire de l'expression génique dans des échantillons de tissu cancéreux fixés, noyés dans une paraffine, et qui permettent au médecin de prévoir si le patient est susceptible de bien réagir au traitement avec un inhibiteur de EGFR.
Agus David
Baker Joffre B.
Cronin Maureen T.
Shak Steve
Cedars-Sinai Medical Center
Genomic Health Inc.
Smart & Biggar
LandOfFree
Gene expression markers for response to egfr inhibitor drugs does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Gene expression markers for response to egfr inhibitor drugs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Gene expression markers for response to egfr inhibitor drugs will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2016442